The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease. 2020

Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
Department of Neurosurgery, Göttingen University Medical Center, Göttingen, Germany.

Intraoperative microelectrode recording (MER) and test-stimulation are regarded as the gold standard for proper placement of subthalamic (STN) deep brain stimulation (DBS) electrodes in Parkinson's disease (PD), requiring the patient to be awake during the procedure. In accordance with good clinical practice, most attending neurologists will request the clinically most efficacious trajectory for definite lead placement. However, the necessity of microelectrode-test-stimulation is disputed, as it may limit the access to DBS therapy, excluding those not willing or incapable of undergoing awake surgery. We retrospectively analyzed the MERs and microelectrode-test-stimulation results with regard to the decision on definite lead placement and clinical outcome in a cohort of 67 PD-patients with STN-DBS. All patients received bilateral quadripolar ring electrodes. To ascertain overall procedural efficacy, we calculated the surgical index (SI) by comparing preoperative motor improvement induced by levodopa to that induced by stimulation 7 to 18 months after surgery, measured as the relative difference between ON and OFF-states on the Unified Parkinson's Disease Rating Scale motor part (UPDRS-3). Additionally, a side-specific surgical index (SSSI) was calculated using the unilateral assessable items of the UPDRS-3. The SSSI where microelectrode-test-stimulation overruled MER were compared to those where the result of microelectrode-test-stimulation was congruent to MER results. A total of 134 electrodes were analyzed. For final lead placement, the central trajectory was chosen in 54% of patient hemispheres. The mean SI was 0.99 (± 0.24). SSSI averaged 1.04 (± 0.45). In 37 lead placements, microelectrode-test-stimulation overruled MER in the final trajectory selection, in 27 of these lead placements adverse effects during microelectrode-test-stimulation were decisive. Neither the number of test electrodes used nor the STN-signal length had an impact on the SSSI. The SSSI did not differ between lead placements with MER/microelectrode-test-stimulation congruency and those where the results of microelectrode-test-stimulation initiated lead placement in a trajectory with shorter STN signal. Intraoperative testing is mandatory to ensure an optimal motor outcome of STN DBS in PD-patients when using quadripolar ring electrodes. However, we also demonstrated that neither the length of the STN-signal on MER nor the number of test electrodes influenced the motor outcome.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008839 Microelectrodes Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. (Dorland, 28th ed) Electrodes, Miniaturized,Electrode, Miniaturized,Microelectrode,Miniaturized Electrode,Miniaturized Electrodes
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000066491 Clinical Decision-Making Process of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention. Medical Decision-Making,Clinical Decision Making,Decision-Making, Clinical,Decision-Making, Medical,Medical Decision Making
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
July 2011, Movement disorders : official journal of the Movement Disorder Society,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
November 2019, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
July 2012, Brain stimulation,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
January 2022, Journal of Parkinson's disease,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
November 2012, Journal of neurological surgery. Part A, Central European neurosurgery,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
January 2024, World neurosurgery,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
January 2023, Frontiers in neurology,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
January 2006, Acta neurochirurgica. Supplement,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
August 2022, Cureus,
Vesna Malinova, and Anabel Pinter, and Cristina Dragaescu, and Veit Rohde, and Claudia Trenkwalder, and Friederike Sixel-Döring, and Kajetan L von Eckardstein
January 2019, Turkish neurosurgery,
Copied contents to your clipboard!